Patent Assignment
Reel/Frame 047291/0551
Assignment of Assignor's Interest
Recorded: 2018-08-06
Pages: 2
Assignor
NAPROMED BIOPHARMACEUTICALS GMBH
Executed: 2016-04-19
Assignee
ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD.
KIRYAT HAMADA, P.O. BOX 3, ARIEL, 40700, ISRAEL
Covered Property
(1)
Treatment of Schizophrenia Using Beta-Caryophyllene and CB2 Receptor Agonists
Application:
15/432,198 →
Publication:
US 2017/0151182
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 6, 2018
From: ANAVI-GOFFER, SHARON
To: ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD.
Reel/Frame 047280/0751 →
Change of Name
Aug 6, 2018
From: ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD.
To: ARIEL SCIENTIFIC INNOVATIONS LTD.
Reel/Frame 047766/0482 →
Assignment of Assignor's Interest
Aug 6, 2018
From: GERTSCH, JUERG
To: NAPROMED BIOPHARMACEUTICALS GMBH
Reel/Frame 046564/0927 →
Assignment of Assignor's Interest
Aug 6, 2018
From: ARIEL SCIENTIFIC INNOVATIONS LTD.
To: ANAVI-GOFFER, SHARON
Reel/Frame 046565/0252 →